Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Johanna

Johanna Annola, Tampere FI

Patent application numberDescriptionPublished
20100285749Hiding A Device - The object of the invention is a method where a first communications device (11-11-2010

Johanna Asklin, Hoellviken SE

Patent application numberDescriptionPublished
20100203075CHLAMYDIA ANTIGENS - The present invention relates to isolated nucleic acid molecules which encode an antigen from a 08-12-2010

Johanna Bergström, Goteborg SE

Patent application numberDescriptionPublished
20100045007AIR-BAG FOR A MOTOR VEHICLE - An air-bag is disclosed for use in a safety arrangement in a motor vehicle. The air-bag comprises a front panel (02-25-2010

Johanna De Sterke, Rotterdam NL

Patent application numberDescriptionPublished
20120116232METHOD FOR DETERMINATION OF UNKNOWN MUTATIONS - The present invention relates to a method of using Raman spectra to identify unknown mutations in a gene, more specifically the filaggrin gene. Specifically, the present invention relates to a method to determine if a person has a homozygous or compound heterozygous mutation in the filaggrin-gene comprising measurement of the presence of tyrosine in the skin. Preferably said measurements are performed by Rama spectrography and on the tsiie of the skin, most preferably on the palm of the hand. Further, when these measurements are taken together with measurements of the NMF content of the skin it, the present invention relates to a method of classifying atopic dermatitis.05-10-2012

Johanna Dominici, Eysines FR

Patent application numberDescriptionPublished
20110007399Head-up Display with Optical Combination Providing Protection Against Solar Illumination - The general field of the invention is that of head-up display systems HUD, protected from solar illumination. An HUD comprises at least one display, an optical system and at least one semi-reflecting plate called a combiner, said optical system and said combiner being arranged so that the image on the display is collimated, the display emitting in at least one first optical spectrum of first spectral width, the display being arranged so as to withstand illumination of a predetermined level. In the display according to the invention, the lateral chromatism of the optical system is sufficiently strong for the level of solar illumination received by the display to be always less than said predetermined level and said lateral chromatism is sufficiently weak for the dispersion of the first spectrum emitted by the display and seen by a user to be less than or equal to the resolution limit of the human eye.01-13-2011
20110255057Multi-Projector Servo-Controlled Display System - A display system includes at least two devices for projecting images and a single screen, each projection device including an image source and projection optics arranged so as to project the image delivered by the image source onto a display region of the screen so that the various images projected from various image sources form a single image without obvious discontinuities, said display system having a device for monitoring and servo-controlling the alignment of the various images. The monitoring and servo-control device is such that the image delivered by each image source includes at least one detection pattern so that the projected image of said detection pattern meets the screen in a detection region located outside of the image display region, the screen having a plurality of light sensing elements, each light sensing element being associated with a projection device and placed so that the projected image of a detection pattern delivered by said projection device forms on its light-sensitive surface, the sensing element being arranged so as to determine the position and/or the orientation of said detection pattern and its photometric properties.10-20-2011
20120086667FORCE MEASURING METHOD FOR A MULTIMODE TOUCHSCREEN DEVICE - A force measuring method for a touchscreen device makes it possible to measure the force applied to the touchscreen. The principle of the invention consists in measuring the displacement of the two plates supporting the conduction lines and columns of the touchscreen, a displacement which is proportional to the force applied. The displacement of the plates is known by analysis of the variation of the capacitive impedance induced by the presence of an actuator to displace the plates.04-12-2012

Johanna FrÄki, Helsinki FI

Patent application numberDescriptionPublished
20110136431Group communication device and method - A method for voice based communication between a number of mobile terminals of a telecommunication network, the method comprising the steps of creating a group of said number of terminals and storing group information in each of the number of terminals, recording a voice message in one of the terminals of the group, dispatching the voice message to the terminals of the group from the one of the terminals, and receiving the voice message at least all other terminals of the group. The step of creating a group of terminals further comprises the steps of coupling together a number of mobile terminals, initiating a group creation command from at least one of the terminals, sending predetermined information from terminal to terminal to each terminal of the number of terminals for forming a group information, and transmitting the group information to all of the terminals thus forming a group of the terminals.06-09-2011

Johanna Hiitola-Keinänen, Oulu FI

Patent application numberDescriptionPublished
20120132351METHOD FOR CREATING A DIFFRACTIVE OPTICAL EFFECT ON A TARGET SURFACE AND A TRANSFER FOIL OF A DIFFRACTIVE OPTICAL ELEMENT - Method of creating a copied fine structure, which produces a diffractive optical effect onto the target surface, includes: using a transfer foil manufactured from thermoplastic, on the surface of which is first created an original fine structure, which produces a diffractive optical effect; placing the transfer foil on the target surface such that the original fine structure is in contact with the target surface; heating the transfer foil to a temperature, which is close to the glass transition temperature of the material of the transfer foil; Simultaneously during the heating or immediately after the heating lightly pressing the transfer foil against the target surface, whereby material from the transfer foil adheres to the target surface; and removing the transfer foil from the target surface, whereby the adhered material makes up a copied fine structure, which is a mirror image of the original fine structure of the transfer foil.05-31-2012

Johanna Hilde, Everett, WA US

Patent application numberDescriptionPublished
20110061571CONCEALABLE, AESTHETIC TRAY UNIT - A multipurpose rotatable tray includes a wall-mountable member rotationally coupled to a tray member, the latter being dually functional as (1) a horizontal support surface and (2) a wall hanging for an aesthetic article, while the tray member is in horizontal and vertical configurations, respectively. The tray member includes an opening for receiving a replaceable aesthetic article, such as, but not limited to, a painting or photograph. The tray unit may be automatically or manually coupled to the wall-mountable member when in the vertical configuration.03-17-2011

Johanna Holldack, Aarhus C DK

Patent application numberDescriptionPublished
20110009481MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES - The invention relates to a medicament containing a compound of general formula (I), where R01-13-2011

Johanna Holldack, Melide CH

Patent application numberDescriptionPublished
20120083473TREATMENT OF CONDITIONS BY TOLL-LIKE RECEPTOR MODULATORS - Provided herein are methods for treating certain conditions, including fibrosis, inflammatory, and autoimmune conditions, with conjugated compounds having Toll-like receptor modulatory activity.04-05-2012

Johanna Hummel-Eisenbeiss, Heidelberg DE

Patent application numberDescriptionPublished
20100113370METHODS AND COMPOUNDS FOR MODULATING INFLAMMATORY PROCESSES - Provided is a method of treating a patient having an inflammatory disease by using a compound which inhibits the ABCC4-mediated release of leukotrienes, a medicament containing such compound and methods for screening such compounds.05-06-2010

Johanna Ivaska, Turku FI

Patent application numberDescriptionPublished
20100160228METHOD FOR INHIBITING OR STIMULATING ANGIOGENESIS IN AN INDIVIDUAL - The invention concerns a method for inhibiting vascular endothelial growth factor receptor 2 (VEGFR2) signalling in an individual by administering an effective amount of an agent capable of activating T cell protein tyrosine phosphatase (TCPTP), and a method for inhibiting angiogenesis and treating or preventing diseases related thereto. Furthermore, this invention concerns a method for stimulating angiogenesis or for treatment or prevention of a disease benefiting from increasing the growth of blood vessels in an individual by inhibiting TCPTP.06-24-2010

Johanna Jakobsdottir, Pittsburgh, PA US

Patent application numberDescriptionPublished
20100216149SUSCEPTIBILITY GENES FOR AGE-RELATED MACULOPATHY (ARM) ON CHROMOSOME 10q26 - Allelic variations in the genes PLEKHA1 and LOC387715 are identified herein as risk factor for Age Related Maculopathy (ARM). A method is therefore provided for identifying a risk of development of ARM in an individual that comprises identification of allelic variations in PLEKHA1 and/or LOC387715. Related apparatus, such as an array, are identified as being useful in implementing those methods.08-26-2010

Johanna Karlsson, Molndal SE

Patent application numberDescriptionPublished
20090111856Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation - The present invention relates to a stable sterilized parenteral formulation comprising an acid susceptible proton pump inhibitor. The formulation, a solid formulation comprising the acid susceptible proton pump inhibitor and optionally pharmaceutically acceptable excipients, has been sterilized in its final container by ionizing radiation. The container may consist of several compartments and separately contains a suitable solvent, which is sterilized, i.e. radiated, at the same time as the solid formulation. Alternatively, the suitable solvent is sterilized separately or aseptically manufactured. The solid formulation is dissolved in a suitable solvent before being administered to the patient, i.e. being prepared ex tempore. The present invention also relates to the prepared sterilized parenteral formulation, the stable solid formulation, processes for obtaining said parenteral formulation and the solid formulation as well as to the therapeutic uses thereof.04-30-2009

Johanna Kolln, Hamburg DE

Patent application numberDescriptionPublished
20090270324COMPLEMENT DEPLETION USING RECOMBINANT HUMAN C-3 DERIVATIVES - The invention provides isolated polypeptides having complement-modulating activity. Specifically, the invention resides in the provision of isolated polypeptides having complement depleting properties, i.e. that effect an efficient consumption of complement in human serum. The current invention thus provides human C3 derivatives that are capable of forming C3 convertases exerting an extended CVF, Bb-like half-life of up several hours, compared to 1.5 minutes of the naturally occurring C3 convertases, thus escaping the physiological degradation mechanisms.10-29-2009

Johanna Kuhlmann-Gottke, Frankfurt DE

Patent application numberDescriptionPublished
20090325942PHENOTHIAZIN DERIVATES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS PHARMACEUTICALS - The invention relates to compounds of the formula 1,12-31-2009
20100261643PHENOTHIAZINE DERIVATIVE HAVING A DOUBLE BOND, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A PHARMACEUTICAL - The present invention relates to substituted phenothiazines with a double bond and physiologically acceptable salts thereof, and their use as a medicament.10-14-2010
20100261644(CYCLOPROPYLPHENYL)PHENYLOXAMIDES, METHOD FOR THE PRODUCTION THEREOF, AND USE OF SAME AS A MEDICAMENT - The invention relates to (cyclopropylphenyl)phenyloxamides and their physiologically tolerated salts, and their use as a medicament.10-14-2010
20100261645(CARBOXYLALKYLENEPHENYL)PHENYLOXAMIDES, METHOD FOR THE PRODUCTION THEREOF AND USE OF SAME AS A MEDICAMENT - The invention relates to (carboxylalkylenephenyl)phenyloxamides and their physiologically tolerated salts, and their use as a medicament.10-14-2010

Johanna Meltaus, Espoo FI

Patent application numberDescriptionPublished
20120086523Method of manufacturing laterally coupled BAW thin films - The invention describes a manufacturing method for an acoustic balanced-unbalanced (balun) or balanced-balanced thin-film BAW filter based on lateral acoustic coupling. In laterally acoustically coupled thin-film BAW filters (LBAW) one can realize transformation from unbalanced to balanced electric signal if the electrodes of the balanced port are placed on the opposite sides of the piezoelectric film. The manufacturing process is simpler than in the corresponding component based on vertical acoustical coupling. The device can also realize impedance transformation.04-12-2012

Johanna Niinimäki, Pori FI

Patent application numberDescriptionPublished
20110180769METHOD FOR PRODUCING MICROCRYSTALLINE TITANIUM OXIDE - A method for producing microcrystalline titanium dioxide in the rutile form having a crystal size below 15 nm by an aqueous method, and a titanium dioxide product doped with silicon obtained by the method. The method generally includes adding a silicon containing compound during crystal formation to provide said titanium dioxide product with a small crystal size.07-28-2011
20110192322METHOD OF PREPARING A WELL-DISPERSABLE MICROCRYSTALLINE TITANIUM DIOXIDE PRODUCT, THE PRODUCT, AND THE USE THEREOF - The invention relates to a method of preparing a well-dispersable, rutile-structured, microcrystalline titanium dioxide product, a product prepared by the method, and an effect paint and a lacquer provided by means of the product. In the method, the titanium dioxide starting material is first treated with a base to have an alkaline pH value, after which it is treated with an acid to have a hydrochloric acid content of 8 to 30 g/l, neutralized, processed, and calcinated. In particular, the preparation method is characterized by the use of a pretreatment chemical before the calcination stage to improve the dispersability.08-11-2011

Johanna Nygren, Lohja FI

Patent application numberDescriptionPublished
20110123692CRYSTALLIZATION OF POLYOL COMPOSITIONS, CRYSTALLINE POLYOL COMPOSITION PRODUCT AND USE THEREOF - The present invention relates to microcrystallized polyol comprising at least two polyols, wherein said polyols are selected from the group consisting of maltitol, xylitol and lactitol and wherein said composition contains at least 35% by weight of each of at least two of said polyols microcrystallized together into a solid microcrystalline product. The present invention also relates to a process for the microcrystallization of polyols into a polyol composition. The microcrystallized polyol composition can be used in confectionery, foodstuffs, oral hygiene products and pharmaceuticals and in dietetic products.05-26-2011

Patent applications by Johanna Nygren, Lohja FI

Johanna Nystedt, Helsinki FI

Patent application numberDescriptionPublished
20090148839METHOD FOR EVALUATING CELL POPULATIONS - The invention describes specific sialylated structures present on human stem cells and cell populations derived thereof. The invention is especially directed to methods to control the status of stem cells by observing changes in sialylation of the cells; and control of potential contaminations of biological materials; and reagents and methods used in connection with the cells in order to avoid alterations of the cell glycosylation by contaminating materials. The invention is further directed to novel stem cells, the glycosylation of which has been specifically altered.06-11-2009
20100047892METHOD FOR MODIFYING CELLS - The invention describes specific sialylated structures present on human stem cells and cell populations derived thereof. The invention is especially directed to methods to control the status of stem cells by changing sialylation and/or fucosylation levels of the cells. The invention is further directed to novel stem cells, the glycosylation of which has been specifically altered. The control methods are preferably mass spectrometric methods.02-25-2010
20110136203ENZYMATICAL MODIF ICATION OF CELL GLYCOSYLATION USING SERUM ALBUMIN AND DIVALENT CATIONS - The invention is directed to a method and kit to control and modify the status of cells, such as human stem cells, by changing their glycosylation, in particular sialylation and fucosylation, levels in a reaction condition where culture medium reagents, such as divalent cations, are present and cells are kept non-adherent. The invention is further directed to novel stem cells, the glycosylation of which has been specifically altered.06-09-2011
20110143373METHOD OF EVALUATING THE INTEGRITY OF THE PLASMA MEMBRANE OF CELLS BY DETECTING GLYCANS FOUND ONLY INTRACELLULARLY - The invention describes novel reagents that can be applied for analysis of the quality of human cells. The method evaluates the integrity of the plasma membrane of the cells by detecting novel glyco structures found only intracellularly. The method can be applied, for example, to demonstrate exposure of therapeutic cell preparation to potentially harmful conditions. It can also be used as a quality control tool in methods in which intact cell membrane is essential and it can be applied in separation of damaged cells from non- damaged.06-16-2011
20110274646Compounds and Combinations - The present invention relates to a combination of a hyaluronan oligomer and/or polymer and a factor capable of mobilizing stem cells. The present invention also relates to a method for altering the relative amounts of blood cells and/or the types of blood cells in a subject by administering the combination to the subject. Further, the present invention relates to a method for mobilizing stem cells to the bloodstream of a subject by administering the combination to the subject. Additionally, the present invention relates to a hyaluronan oligomer and/or polymer.11-10-2011

Patent applications by Johanna Nystedt, Helsinki FI

Johanna Panula-Perala, Oulu FI

Patent application numberDescriptionPublished
20100099164METHOD FOR CONTROLLING THE GROWTH OF CELL CULTURE - In a method for controlling the growth of microbes grown in a medium to high cell-densities by the fed-batch technology, a two-phase system, having a liquid phase (cultivation medium) and a solid or gel phase, the solid or gel phase provides a source of substrate-delivering polymer which is turned by an enzyme in a controlled way into a growth-limiting substrate or pH adjusting agent. Also described is a method for restricting the synthesis of growth-limiting metabolites and preventing oxygen-depletion in microbial cell cultures.04-22-2010

Johanna Plijter, Elst NL

Patent application numberDescriptionPublished
20090297663BREAD IMPROVER - Structural properties of bread and other bakery products based on leavened flour are improved by incorporating into the flour at least 0.1 wt. % of a polysaccharide which is characterised by a molecular weight of at least 1012-03-2009

Johanna Qvarnstrom, Huddinge SE

Patent application numberDescriptionPublished
20110014243PHARMACEUTICAL COMPOSITIONS - Compositions are described in which certain thyroid hormone receptor-binding compounds are formulated together with a basic filler. Such formulation acts to prevent the formation of undesired reaction products. The compositions may be formed into granules or a tablet which may optionally be enterically coated.01-20-2011

Johanna Ramström, Malmo SE

Patent application numberDescriptionPublished
20110209061METHOD FOR PLAYING BACK AUDIO FILES WITH AN AUDIO REPRODUCTION DEVICE - A method for playing back audio files with an audio reproduction device and an audio reproduction device are described.08-25-2011

Johanna Schuetz-Widoniak, Seeheim-Jugenheim DE

Patent application numberDescriptionPublished
20120070673COATING COMPOSITION - The present invention relates to a pigmented coating composition for an automobile clear coat, to the use of a coating composition of this type, to an automobile clear coat, and to a process for the coating of an automobile with a clear coat.03-22-2012

Johanna Schuetz-Widoniak, Darmstadt DE

Patent application numberDescriptionPublished
20100120935BINDING AGENT - The present invention relates to binders, to processes for the preparation thereof, and to the use thereof in formulations, surface coatings, inks and plastics.05-13-2010

Johanna Tiitola, Helsinki FI

Patent application numberDescriptionPublished
20110151850METHODS, APPARATUSES AND COMPUTER PROGRAM PRODUCTS FOR AUTOMATICALLY SAVING INFORMATION ASSOCIATED WITH ONE OR MORE UNKNOWN CONTACTS - An apparatus for generating information associated with an unknown contact(s) may include a processor and a memory storing executable computer program code that causes the apparatus to at least perform operations including determining if a communication identifier(s) is in contact data responsive to determining that a communication is based on the communication identifier. The computer program code may cause the apparatus to detect information relating to the communication identifier, which may include data indicating whether previous communications of the communication identifier are identified. The data includes details of the previous communications. The computer program code may cause the apparatus to provide the detected information to a display of the apparatus in response to initiation of an outgoing/incoming communication and may determine whether to complete initiation of the outgoing communication or ignore the incoming communication based on data of the previous communications. Corresponding computer program products and methods are also provided.06-23-2011

Johanna Tinhofer, Vienna AT

Patent application numberDescriptionPublished
20090324501Vaccine Carrier - The present invention relates to a hypoallergenic protein consisting of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to at least one second non-allergenic protein or fragment thereof.12-31-2009

Johanna Tommiska, Espoo FI

Patent application numberDescriptionPublished
20100159458METHOD FOR PREDICTING THE RESPONSE TO A THERAPY - The present invention relates to cancer treatment and particularly to a method for predicting the response of a cancer subject to a given therapy. The invention provides a gene or gene product useful as a predictive marker for classifying the subjects. Also disclosed are diagnostic tools, test kits and compositions and their use in the method. The invention is based on the use of NAD(P)H:Quinone oxidoreductase 1, NQO1, which enables the identification and classification of subjects who would benefit from being excluded from a treatment, particularly from anthracycline-based adjuvant chemotherapy with epirubicin.06-24-2010

Johanna Wachtmeister, Sodertalje SE

Patent application numberDescriptionPublished
20080319231Process for the Preparation of Alkyl Phosphinates - The invention relates to a new process for the production of alkyl dialkoxyalkylphosphinates. A hypophosphite salt is used in the process.12-25-2008
20100130773PROCESS FOR THE SYNTHESIS OF ALKYL PHOSPHINIC ACIDS BY INITIATION OF AN AMINE AND AN AMINEOXIDE - The present invention relates to a new process for the synthesis of alkyl phosphinic acids, and more particularly to a coupling reaction between an alkylhalide and a hypophosphorous acid derivative in the presence of an amine and an amineoxide.05-27-2010

Johanna Ylikotila, Raisio FI

Patent application numberDescriptionPublished
20100173425High Capacity Solid Phase - A high capacity solid phase for bioaffinity assays and other solid phase applications prepared by coating a solid support with an analyte-specific biomolecule in the presence of a zwitterionic additive is described. Structures prepared according to the invention provide high capacity solid phases with enhanced binding properties, which are advantageous for any solid phase based assay.07-08-2010